Quantification of valerenic acid and its derivatives in some species of Valeriana L. and Centranthus longiflorus Stev.

Asian Journal of Plant Sciences

Volumn 7, Issue 2, 2008, Pages 195-200

  Hassan, Ebrahimzadeh ^a   Tayebeh, Radjabian ^b   Samaneh, Ekhteraei Tousi ^a   Zeinalabedin, Bashiri Sadr ^c   Niknam, Vahid ^a   Mehdi, Zarrei ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b SHAHED UNIVERSITY   (Iran)

^c IRANIAN RESEARCH ORGANIZATION FOR SCIENCE AND TECHNOLOGY IROST   (Iran)

Author keywords

Medicinal compounds; TLC; UV spectrophotometry; Valerianaceae

Indexed keywords

CENTRANTHUS; CENTRANTHUS LONGIFLORUS; VALERIANA; VALERIANA OFFICINALIS; VALERIANACEAE;

EID: 42149155439     PISSN: 16823974     EISSN: 18125697     Source Type: Journal    
DOI: 10.3923/ajps.2008.195.200     Document Type: Article

References (15)

1. Bell, Ch.D. and M.J. Donoghue, 2005. Phytogeny and biogeography of Valerianaceae (Dipsacales) with special reference to the South American valerians. Organ. Diversity Evol., 5 (2): 147-159.
2. Bos, R., 1997. Analytical and phytochemical studies on valerian and valerian based preparations. Offsetdrukkerij Ridderprint B.V., Ridderkerk, Groningen.
3. Circosta, C., R. De Pasquale, S. Samperi, A. Pinoand and F. Occhiuto, 2007. Biological and analytical characterization of two extracts from Valeriana officinalis. J. Ethnopharmacol., 112 (2): 361-367.
4. Fernández, S., C. Wasowski, A.C. Paladini and M. Marder, 2004. Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis. Pharmacol. Biochem. Behav., 77 (2): 399-404.
5. Hendriks, H., R. Bos, D.P. Allersma, T.M. Malingré and A.S. Koster, 1981. Pharmacological screening of valerenal and other components of essential oil of Valeriana officinalis. Planta Med., 42: 62-68.
6. Hendriks, H., R. Bos, H. J. Woerdenbag and A.S. Koster, 1985. Central nervous depressant activity of valerenic acid in the mouse. Planta Med., 51: 28-31.
7. Hidalgo, O., T. Garnatje, A. Susanna and J.L. Mathez, 2004. Phytogeny of Valerianaceae based on matK and ITS markers, with reference to matK individual polymorphism. Ann. Bot. (Oxford), 93: 283-293.
8. Li, M.Y., J.C. Ahn, K.S. Kim, O.T. Kim, Y.J. Park and B. Hwang, 2006. Comparison of valerenic acids and valepotriates production according to the culture conditions for cultured roots of Valeriana fauriei var. dasycarpa. Korean J. Med. Crop Sci., 14 (2): 101-106.
9. Miyasaka, L.S, A.N. Atallah and B.G. Soares, 2006. Valerian for anxiety disorders. Cochrane Database Syst Rev., Issue 4. Art. No. CD004515. DOI: 10.1002/ 14651858. CD004515. pub2.
10. Moussavi-Allashlou, E., 2001. Flora of Iran (Valerianaceae). Research Institute of Forests and Rangelands Publications, Tehran.
11. Murakami, N., Y. Ying, M. Kawanishi, S. Aoki, N. Kudo, M. Yoshida, E.E. Nakayama, T. Shioda and M. Kobayashi, 2002. New Rev-transport inhibitor with anti-HJV activity from Valerianae Radix. Bioorg. Med. Chem. Lett., 12 (20): 2807-2810.
12. Singh, N., A.P. Gupta, B. Singh and V.K. Kau, 2006. Quantification of valerenic acid in Valeriana jatamansi and Valeriana officinalis by HPTLC. Chromatographia, 63 (3/4): 209-213.
13. Upton, R., C. Petrone, D. Swisher, A. Goldberg, M. McGuffin and N.D. Pizzorno, 1999. Valerian root, Valeriana officinalis, Analytical, quality control and therapeutic monograph. American Herbal Pharmacopoeia (AHP) and Therapeutic Compendium.
14. Wagner, H., S. Bladt and E.M. Zgainski, 1984. Plant Drug Analysis. A Thin Layer Chromatography Atlas, Translated by Th.A. Scott. Springer-Verlag, Berlin, Heidelberg, New York.
15. Wills, R.B.H. and D. Shohet, 2003. Production of High Quality Australian Valerian Products. A report for the Rural Industries Research and Development Corporation, RIRDC Publication.